Monthly information on share capital and company voting rights

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, July 05, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

For further information on Cellectis, please contact:     

Media contact:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, [email protected]

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contacts:

Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, [email protected]

Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577

Attachment

• Voting_Rights_PR_June2024_EN.pdf

You May Also Be Interested In

• Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
• Pepeto vs AlphaPepe: Why AlphaPepe’s Live AI DEX Gives It the Edge in the Next Pepe Coin Race
• IGNITE Social Enterprise Enters Sub-Saharan Africa